Germline Warfare
By Ralph Brave,
The Nation
| 04. 07. 2003
A most remarkable event occurred in the weeks preceding the
June 2000 announcement of the completion of the first draft
of the human genome DNA code: One of the leaders of the genome
project publicly called for strict limits on what the scientific
community should be permitted to do with the human genetic blueprint
now in hand.
At a conference at MIT, Dr. Eric Lander, leader of the team
that decoded the largest portion of the genome, called the conference
to attention with this surprisingly stark suggestion:
Already, there are well-meaning discussions about improving
the human DNA. I find this somewhat hubristic myself. [The human
genome] has been 3.5 billion years in the making. We've been
able to read it for the last, oh, I don't know, year or so.
And we suddenly think we could write the story better? It's
very amusing.
There is the prospect that by changing things we might put
off aging, prevent cancer, improve memory. I find it a very
difficult question. For my own part, I would put an absolute
ban in place on...
Related Articles
By Ian Sample, The Guardian | 07.04.2024
Biological models of human embryos that can develop heartbeats, spinal cords and other distinctive features will be governed by a code of practice in Britain to ensure that researchers work on them responsibly.
Made from stem cells, they mimic, to...
By Kevin Davies, Genetic Engineering & Biotechnology News | 06.27.2024
Physician-scientist Matthew Porteus, MD, PhD, has been a mainstay in the genome editing field for more than two decades. He trained at Stanford University Medical School before completing his residency and hematology/oncology fellowship at Boston Children’s Hospital/Dana Farber Cancer Institute...
By Peter Aldhous, Scientific American | 07.02.2024
In June a notice posted on the website of the journal Nature set a new scientific record. It withdrew what is now the most highly cited research paper ever to be retracted.
The study, published in 2002 by Catherine Verfaillie...
By Robert F. Service, Science | 07.04.2024
Image by Ed Uthman from Flickr
Last year, the U.S. Food and Drug Administration (FDA) approved two gene therapy procedures that can treat and, in some cases essentially cure sickle cell disease, a genetic blood disorder that causes pain and...